Source: Stem Cells: Therapeutic Applications. Unidade: IQ
Subjects: DOENÇAS NEURODEGENERATIVAS, DOENÇAS CARDIOVASCULARES, NEUROGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ANDREJEW, Roberta et al. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases. Stem Cells: Therapeutic Applications. Tradução . Cham: Springer Nature, 2019. . Disponível em: https://doi.org/10.1007/978-3-030-31206-0_14. Acesso em: 05 out. 2024.APA
Andrejew, R., Glaser, T., Giacomelli, Á. O., Ribeiro, D. E., Godoy, M. A. de, Granato, A. E. C., & Ulrich, H. (2019). Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases. In Stem Cells: Therapeutic Applications. Cham: Springer Nature. doi:10.1007/978-3-030-31206-0_14NLM
Andrejew R, Glaser T, Giacomelli ÁO, Ribeiro DE, Godoy MA de, Granato AEC, Ulrich H. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases [Internet]. In: Stem Cells: Therapeutic Applications. Cham: Springer Nature; 2019. [citado 2024 out. 05 ] Available from: https://doi.org/10.1007/978-3-030-31206-0_14Vancouver
Andrejew R, Glaser T, Giacomelli ÁO, Ribeiro DE, Godoy MA de, Granato AEC, Ulrich H. Targeting purinergic signaling and cell therapy in cardiovascular and neurodegenerative diseases [Internet]. In: Stem Cells: Therapeutic Applications. Cham: Springer Nature; 2019. [citado 2024 out. 05 ] Available from: https://doi.org/10.1007/978-3-030-31206-0_14